ERBB2 and head and neck squamous cell carcinoma: We hypothesize that heterogeneous tumors such as PDAC and HNSCC exhibiting diverse patterns of tumor-associated cell surface receptors (EGFR, TfR, HER-2) over-expression, can be selectively targeted using PDT directed against EGFR, TfR, and HER-2 concurrently.